Vaccines on Mucosal Immunity

  • 1,786

    Total downloads

  • 8,207

    Total views and downloads

About this Research Topic

Submission closed

Background

Vaccine prevention of infections is one of the most effective ways to protect against the occurrence of diseases and their spread. At the same time, most modern vaccine preparations use either a weakened (inactivated) pathogen (bacterial or viral) or a modified toxin to form immune protection. During vaccination, the introduction of the antigen into the body is most often carried out by injecting the drug together with a set of additional substances with adjuvant or stabilizing features. Usually, the criterion for vaccine effectiveness is the level of immunoglobulins in the blood. This approach, with slight variations, is successfully used for vaccination in all developed countries of the world. However, recently an increasing number of researchers have been thinking about the feasibility of a modern vaccination system, paying attention to the possible health risks of those vaccinated due to the main vaccine preparation or additional vaccine components.

When pathogenic microorganisms enter through the respiratory tract or the digestive apparatus, the first barrier that determines the possibility of penetration of the pathogen into the body, and hence the onset of infectious disease, is the mucous layer. The immune system of the mucous membranes of the body plays a huge role in the development, maintenance and regulation of immune status and thus makes up an important component of the immune system. The immune system of the mucous membranes of different body systems closely interacts with each other. This relationship is especially close between the digestive and respiratory tracts (1). It is no coincidence that in recent years a significant number of vaccine developments involve vaccination by administering a vaccine preparation to the mucous membranes. It is essential that when using the mucosal vaccine, the mucosa in different parts of the body reacts as a whole (1). It should be noted, that there are already several successful vaccine preparations that use the non-injection route of vaccination. Currently, 5 mucosal vaccines (cholera, typhoid, polio, rotavirus, influenza) are registered, with the first four vaccines suggesting the oral route of administration. There are several reasons for choosing oral vaccines for mucosal immunization: 1. Ease of administration, which provides the possibility of self-vaccination, 2. Organization of the intestinal mucosa, which makes it possible to perceive foreign antigens through specific M cells, practically free from the mucus layer with a large number of compactly located specialized cells of the immune system (dendritic cells, T lymphocytes of various classes and B lymphocytes), which ensure the rapid formation of immune responses, 3. Lesser side effects, 4. Ease of production and low cost. A limitation to the creation of successful oral vaccines is based on the organization of the gastrointestinal tract, which involves the rapid destruction of pathogens or pathogenic factors (antigens) under the influence of gastric juice, bile and intestinal enzymes.

The problem of antigen delivery to intestinal M cells may be solved by using bacterial vectors of vaccine antigens – probiotic bacteria. Probiotic strains have been well studied for safety for the body, can remain viable after passing through the gastric barrier, improve inter-epithelial connections, and can also generate a number of surface structures that enhance the effectiveness of vaccination. Probiotics have been successfully used as vectors, the DNA of which has been successfully introduced with plasmid constructs that ensure the expression of antigens of pathogenic bacteria (1, 2, 3, 4). Another problem with mucosal vaccines is their relatively difficult assessment of efficacy because of usually small specific IgG response. However, the present pandemic infection of SARS-Cov-2 showed that IgG levels do not always correlate with protection against the virus. In summary,

The current Research Topic aims to update the scientific community on recent developments concerning mucosal immunity and protective vaccines for mucosal immunization. We welcome authors to submit original, review and mini-review articles focused on mucosal immunity and vaccines targeting mucosal immunity.

Information for the authors: All papers related to the subject of oral, nasal intestinal, or vaginal immunity and vaccines which are developing for mucosal immunization are eligible.

References:
1. Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun. (2001) 69(12):7481-6.
2. Ma Y, Luo Y, Huang X, Song F, Liu G. Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli. Microbiology. (2012) 158(2):498-504.
3. de Azevedo M, Karczewski J, Lefévre F, Azevedo V, Miyoshi A, Wells JM, Langella P, Chatel JM. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A. BMC Microbiol. (2012) 19;12:299.
4. Laiño J., Villena J., Zelaya H., Moyano R.O., Salva S., Alvarez S., Suvorov A. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve the resistance of infant mice to Streptococcus pneumoniae infection PLoS ONE. 2018. Т. 13. № 11. С. e0206661

Research Topic Research topic image

Keywords: Vaccines, Mucosal immunity, Pathogens, Infectious agents

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.